215 related articles for article (PubMed ID: 12112023)
21. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
Irazoqui AP; Boland RL; Buitrago CG
J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
[TBL] [Abstract][Full Text] [Related]
22. Modulation of tyrosine phosphorylation signalling pathways by 1alpha,25(OH)2-vitamin D3.
Boland R; Buitrago C; De Boland AR
Trends Endocrinol Metab; 2005 Aug; 16(6):280-7. PubMed ID: 16002300
[TBL] [Abstract][Full Text] [Related]
23. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
24. Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms.
Boyan BD; Dean DD; Sylvia VL; Schwartz Z
Connect Tissue Res; 2003; 44 Suppl 1():130-5. PubMed ID: 12952186
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D receptor levels and binding are reduced in aged rat intestinal subcellular fractions.
González Pardo V; Boland R; de Boland AR
Biogerontology; 2008 Apr; 9(2):109-18. PubMed ID: 18060514
[TBL] [Abstract][Full Text] [Related]
26. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
Hughes PJ; Brown G
J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of Pdia3-dependent 1α,25-dihydroxy vitamin D3 signaling in musculoskeletal cells.
Boyan BD; Chen J; Schwartz Z
Steroids; 2012 Aug; 77(10):892-6. PubMed ID: 22569272
[TBL] [Abstract][Full Text] [Related]
28. Caveolae and caveolin-1 are implicated in 1alpha,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells.
Buitrago C; Boland R
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):169-75. PubMed ID: 20211253
[TBL] [Abstract][Full Text] [Related]
29. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro.
Huhtakangas JA; Olivera CJ; Bishop JE; Zanello LP; Norman AW
Mol Endocrinol; 2004 Nov; 18(11):2660-71. PubMed ID: 15272054
[TBL] [Abstract][Full Text] [Related]
30. Evidence that TRPC3 is a molecular component of the 1alpha,25(OH)2D3-activated capacitative calcium entry (CCE) in muscle and osteoblast cells.
Santillán G; Baldi C; Katz S; Vazquez G; Boland R
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):291-5. PubMed ID: 15225788
[TBL] [Abstract][Full Text] [Related]
31. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
Mizwicki MT; Bishop JE; Norman AW
Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
[TBL] [Abstract][Full Text] [Related]
32. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
Peleg S; Ismail A; Uskokovic MR; Avnur Z
J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
[TBL] [Abstract][Full Text] [Related]
33. Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.
Pospechova K; Rozehnal V; Stejskalova L; Vrzal R; Pospisilova N; Jamborova G; May K; Siegmund W; Dvorak Z; Nachtigal P; Semecky V; Pavek P
Mol Cell Endocrinol; 2009 Feb; 299(2):178-87. PubMed ID: 19133314
[TBL] [Abstract][Full Text] [Related]
34. Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.
Okamura M; Takano Y; Saito Y; Yao J; Kitamura M
Nephrol Dial Transplant; 2009 Oct; 24(10):3006-12. PubMed ID: 19474283
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a 1 alpha,25-dihydroxyvitamin D3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus.
Kato A; Bishop JE; Norman AW
Biochem Biophys Res Commun; 1998 Mar; 244(3):724-7. PubMed ID: 9535732
[TBL] [Abstract][Full Text] [Related]
36. Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells.
Pojednic RM; Ceglia L; Olsson K; Gustafsson T; Lichtenstein AH; Dawson-Hughes B; Fielding RA
Calcif Tissue Int; 2015 Mar; 96(3):256-63. PubMed ID: 25479835
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic corruption of VDR signalling in malignancy.
Abedin SA; Banwell CM; Colston KW; Carlberg C; Campbell MJ
Anticancer Res; 2006; 26(4A):2557-66. PubMed ID: 16886664
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
39. Effects of 1,25-dihydroxy-vitamin D3 on phosphate accumulation by myoblasts.
Bellido T; Boland R
Horm Metab Res; 1991 Mar; 23(3):113-6. PubMed ID: 1650748
[TBL] [Abstract][Full Text] [Related]
40. A novel bile acid-activated vitamin D receptor signaling in human hepatocytes.
Han S; Li T; Ellis E; Strom S; Chiang JY
Mol Endocrinol; 2010 Jun; 24(6):1151-64. PubMed ID: 20371703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
